Perfil
Jeffrey R.
Latts is an Independent Director at Allos Therapeutics, Inc. since 2007.
Previously, he served as the Chief Medical Officer at Berlex, Inc. from 1990 to 2001.
He then worked as the Executive Vice President at Exelixis, Inc. from 2001 to 2007.
Additionally, he has held positions as the Chief Medical Advisor at Virobay, Inc. and as the Vice President-Clinical Research at Wyeth-Ayerst Research.
Dr. Latts completed his undergraduate and doctorate degrees at the University of Minnesota.
Cargos activos de Jeffrey R. Latts
| Empresas | Cargo | Inicio |
|---|---|---|
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Director/Miembro de la Junta | 25/04/2007 |
Antiguos cargos conocidos de Jeffrey R. Latts.
| Empresas | Cargo | Fin |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | 12/01/2007 |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | Director Técnico/Científico/I+D | 01/01/2001 |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Director Técnico/Científico/I+D | - |
Formación de Jeffrey R. Latts.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth-Ayerst Research |
- Bolsa de valores
- Insiders
- Jeffrey R. Latts
















